Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial

被引:0
|
作者
Stefan Knop
Maria-Victoria Mateos
Meletios A. Dimopoulos
Kenshi Suzuki
Andrzej Jakubowiak
Chantal Doyen
Paulo Lucio
Zsolt Nagy
Ganna Usenko
Ludek Pour
Mark Cook
Sebastian Grosicki
Andre Crepaldi
Anna Marina Liberati
Philip Campbell
Tatiana Shelekhova
Sung-Soo Yoon
Genadi Losava
Tomoaki Fujisaki
Mamta Garg
Jianping Wang
Susan Wroblewski
Anupa Kudva
Katharine S. Gries
John Fastenau
Jesus San-Miguel
Michele Cavo
机构
[1] Würzburg University Medical Center,Department of Haematology and Oncology
[2] University Hospital of Salamanca–Instituto de Investigación Biomédica de Salamanca,Department of Internal Medicine
[3] National and Kapodistrian University of Athens,Institute of Hematology, Department of Experimental, Diagnostic and Specialty Medicine
[4] Japanese Red Cross Medical Center,undefined
[5] University of Chicago Medical Center,undefined
[6] Université Catholique of Louvain,undefined
[7] CHU UCL Namur,undefined
[8] Champalimaud Centre for the Unknown,undefined
[9] Semmelweis University,undefined
[10] Dnipropetrovsk City Multidisciplinary Clinical Hospital No. 4,undefined
[11] University Hospital Brno,undefined
[12] University Hospitals Birmingham NHS Trust,undefined
[13] Silesian Medical University,undefined
[14] Clinica de Tratamento E,undefined
[15] Azienda Ospedaliera “Santa Maria”,undefined
[16] Andrew Love Cancer Centre,undefined
[17] Clinic of Professional Pathology,undefined
[18] Seoul National University College of Medicine,undefined
[19] LTD “Medinvent” Institute of Health,undefined
[20] Matsuyama Red Cross Hospital,undefined
[21] Leicester Royal Infirmary,undefined
[22] Janssen Research and Development,undefined
[23] Janssen Research & Development,undefined
[24] LLC,undefined
[25] Clínica Universidad de Navarra–Centro de Investigación Médica Aplicada,undefined
[26] Instituto de Investigación Sanitaria de Navarra,undefined
[27] Centro de Investigación Biomédica en Red de Cáncer,undefined
[28] University of Bologna,undefined
来源
BMC Cancer | / 21卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial
    Knop, Stefan
    Mateos, Maria-Victoria
    Dimopoulos, Meletios A.
    Suzuki, Kenshi
    Jakubowiak, Andrzej
    Doyen, Chantal
    Lucio, Paulo
    Nagy, Zsolt
    Usenko, Ganna
    Pour, Ludek
    Cook, Mark
    Grosicki, Sebastian
    Crepaldi, Andre
    Liberati, Anna Marina
    Campbell, Philip
    Shelekhova, Tatiana
    Yoon, Sung-Soo
    Losava, Genadi
    Fujisaki, Tomoaki
    Garg, Mamta
    Wang, Jianping
    Wroblewski, Susan
    Kudva, Anupa
    Gries, Katharine S.
    Fastenau, John
    San-Miguel, Jesus
    Cavo, Michele
    BMC CANCER, 2021, 21 (01)
  • [2] Health-related quality of life in patients with newly diagnosed multiple myeloma who are ineligible for stem cell transplantation: Results from the ALCYONE trial.
    Gries, Katharine
    Fastenau, John
    Chen, Ying
    Wang, Jianping
    Ho, Kai Fai
    Wroblewski, Susan
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] Health-Related Quality of Life in Transplant-Ineligible Patients With Newly Diagnosed Multiple Myeloma: Findings From the Phase III MAIA Trial
    Perrot, Aurore
    Facon, Thierry
    Plesner, Torben
    Usmani, Saad Z.
    Kumar, Shaji
    Bahlis, Nizar J.
    Hulin, Cyrille
    Orlowski, Robert Z.
    Nahi, Hareth
    Mollee, Peter
    Ramasamy, Karthik
    Roussel, Murielle
    Jaccard, Arnaud
    Delforge, Michel
    Karlin, Lionel
    Arnulf, Bertrand
    Chari, Ajai
    He, Jianming
    Ho, Kai Fai
    Van Rampelbergh, Rian
    Uhlar, Clarissa M.
    Wang, Jianping
    Kobos, Rachel
    Gries, Katharine S.
    Fastenau, John
    Weisel, Katja
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03) : 227 - +
  • [4] Health-related quality of life (HRQOL) in transplant-ineligible patients (pts) with newly diagnosed multiple myeloma (NDMM): Results from the first trial.
    Delforge, Michel
    Minuk, Leonard
    Eisenmann, Jean-Claude
    Arnulf, Bertrand
    Canepa, Letizia
    Fragasso, Alberto
    Leyvraz, Serge
    Langer, Christian
    Ezaydi, Yousef
    Vogl, Dan T.
    Giraldo-Castellano, Pilar
    Yoon, Sung-Soo
    Martins, Angelo
    Zarnitsky, Charles
    Barbe, Martine Escoffre
    Lemieux, Bernard
    Proskorovsky, Irina
    Ervin-Haynes, Annette L.
    Houck, Vanessa
    Facon, Thierry
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [5] An overview of the VISTA trial: newly diagnosed, untreated patients with multiple myeloma ineligible for stem cell transplantation
    Spicka, Ivan
    Mateos, M. V.
    Redman, K.
    Dimopoulos, M. A.
    Richardson, P. G.
    IMMUNOTHERAPY, 2011, 3 (09) : 1033 - 1040
  • [6] HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS (PTS) WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): THE FIRST TRIAL
    Delforge, M.
    Minuk, L.
    Eisenmann, J. C.
    Arnulf, B.
    Canepa, L.
    Fragasso, A.
    Leyvraz, S.
    Langer, C.
    Ezaydi, Y.
    Vogl, D. T.
    Giraldo-Castellano, P.
    Yoon, S. S.
    Martins, A.
    Zarnitsky, C.
    Escoffre-Barbe, M.
    Lemieux, B.
    Proskorovsky, I.
    Monzini, M. Silva
    Ervin-Haynes, A.
    Houck, V.
    Facon, T.
    HAEMATOLOGICA, 2014, 99 : 109 - 110
  • [7] Lenalidomide, melphalan, and prednisone, followed by lenalidomide maintenance, improves health-related quality of life in newly diagnosed multiple myeloma patients aged 65 years or older: results of a randomized phase III trial
    Dimopoulos, Meletios A.
    Delforge, Michel
    Hajek, Roman
    Kropff, Martin
    Petrucci, Maria T.
    Lewis, Philip
    Nixon, Annabel
    Zhang, Jingshan
    Mei, Jay
    Palumbo, Antonio
    HAEMATOLOGICA, 2013, 98 (05) : 784 - 788
  • [8] HEALTH-RELATED QUALITY OF LIFE (HRQOL) OF PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA (TIE NDMM) AND RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) IN PHASE III RANDOMIZED CONTROLLED TRIALS (RCTS): A TARGETED LITERATURE REVIEW
    Charu, R.
    Manupati, R.
    Singh, J. A.
    Rai, M. K.
    Gautam, R.
    Kalsey, M. S.
    Prasanna, R.
    VALUE IN HEALTH, 2022, 25 (07) : S546 - S546
  • [9] Health-related quality of life in elderly, newly diagnosed multiple myeloma patients treated with VMP vs. MP: results from the VISTA trial
    Delforge, Michel
    Dhawan, Ravinder
    Robinson, Don, Jr.
    Meunier, Juliette
    Regnault, Antoine
    Esseltine, Dixie-Lee
    Cakana, Andrew
    van de Velde, Helgi
    Richardson, Paul G.
    San Miguel, Jesus F.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2012, 89 (01) : 16 - 27
  • [10] Health-Related Quality of Life after Autologous Stem Cell Transplantation for Multiple Myeloma
    Chakraborty, Rajshekhar
    Hamilton, Betty K.
    Hashmi, Shahrukh K.
    Kumar, Shaji K.
    Majhail, Navneet S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (08) : 1546 - 1553